Abstract:OBJECTIVES(1) To investigate the levels of the serum soluble endothelial growth factor receptor-1 in women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. For more, to analyze the relativity between the levels of the serum soluble vascular growth factor receptor-1 and preeclampsia. (2) To detect the expression of the membrane-bound VEGFR-1 protein in the placenta tissue of the women with preeclampsia and compare the difference between the groups of the mild preeclampsia, severe preeclampsia and eclampsia, Then to analyze the relativity between the expression of the membrane-bound endothelial growth factor receptor-1 and preeclampsia.METHODS(1) The serum levels of sVEGFR-1 in 10 women with mild preeclampsia, 10 women with severe preeclampsia, 10 women with eclampsia, 10 women without preeclampsia were detected by the quantitative sandwich enzyme immunoassay technique. (2) Immunohistochemistry and quantitative analysis were used to detect membrane-bound VEGFR-1 contents and distribution in the placenta tissue.RESULTS(1) The results showed that the serum sVEGFR-1 levels of all preeclampsia groups were relatively higher than those of control group (P < 0.05) and that there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia. (2) In placentas, the positive staining was detected predominantly in the membranes of villus syncytiotrophoblast cells, extravillous trophoblast cells, and villus endothelial cells. In fetal membranes, the positive staining was detected predominantly in amnionic endothelial cells. (3) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group. There were significant differences between membrane-bound VEGFR-1 contents of the mild preeclampsia,severe preeclampsia and eclampsia (P < 0.05). (4) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/ membrane-bound VEGFR-1) was relatively higher than that of control group (P < 0.05) and there were significant differences between the groups of the mild preeclampsia, severe preeclampsia and eclampsia (P < 0.05).CONCLUSIONS(1) The serum sVEGFR-1 levels of preeclampsia groups were relatively higher than those of control group, the VEGFR-1 may be related to preeclampsia. (2) The contents of membrane-bound VEGFR-1 in placenta of preeclampsia groups were relatively lower than that of control group, the membrane-bound VEGFR-1 may relate to preeclampsia. (3) The ratio of the sVEGFR-1 concentration in serum and the membrane-bound VEGFR-1 contents in placenta of preeclampsia groups (sVEGFR-1/membrane-bound VEGFR-1) was relatively higher than that of control group, the preeclampsia may contribute to VEGFR-1/ PLGF and sVEGFR-1/membrane-bound.

The expressions and significances of VEGF and p53 in placenta of normal pregnancy and pre-eclampsia patients

Progress in Soluble Vascular Endothelial Growth Factor Receptor-1 and Preeclampsia

Expression and clinical implication of endothelial glycoprotein,vascular endothelial growth factor and its receptor 1 in preeclampsia

The expression of CXCL12 and VEGF in preeclampsia

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

Expression and Significance of Mir155 and Vascular Endothelial Growth Factor in Placenta of Rats with Preeclampsia

[The Relativity of Vascular Endothelium Growth Factor Receptor-1 and Preeclampsia].

Association of a Reduction of G-protein Coupled Receptor 30 Expression and the Pathogenesis of Preeclampsia

Effect of Vascular Endothelial Growth Factor on Pre-Eclampsia in Pregnant Rats

Relationship of Hypoxia-inducible Factor-1αand Endoglin Expression in Placenta and Soluble Endoglin in Serum in Preeclampsia

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

Expressions and significance of p-p38, caspase-3 and caspase-8 in placenta of patients with preeclampsia

[Vasohibin and VEGF Protein Levels in Placentae from Pregnancies Complicated by Severe Pre-Eclampsia].

Expression of RANKL in placenta and its correlation with preeclampsia

Interaction Between Peroxisome Proliferator-Activated Receptor-Gamma and Tumor Necrosis Factor-Alpha in Pathogenesis of Severe Preeclampsia

Relationship of angiostation and VEGF and preeclampsia

Expression and Significance of Vascular Endothelial Growth Factor and Its Receptor Fms-Like Tyrosine Kinase-1 in Placenta for Patients with Intrahepatic Cholestasis of Pregnancy

Expression of Vascular Endothelial Growth Factor in Placenta with Intrahepatic Cholestasis of Pregnancy

Relationship Between Expressions of Á2-Hs-glycoprotein Gene Mrna and Protein in Placenta and Insulin Resistance in Preeclampsia Patients

Significance of vascular endothelial growth factor level in maternal/fetal interface of pregnant women with pregnancy-induced hypertension

Expression level of PTEN in placenta tissues of preeclampsia patients and normal pregnancy